Evidence map›Paper›PMID 42406873›Full record

ArticlePloS one2026

Barriers and facilitators to healthcare utilization amongst people living with sickle cell disease in the United States: A scoping review.

Christina Ruan, Joyce Gyamfi, Nana Osei-Tutu, Shreya Meda, Lydia Samuels, Nousheen Inayat, Sukruthi Thunga, Elizabeth Noble, Dorice L Viera, Deborah Adenikinju and 4 more

Abstract readScoping Review
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Christina RuanDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.ORCID https://orcid.org/0000-0001-6583-6448
Joyce GyamfiDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.
Nana Osei-TutuDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.
Shreya MedaDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.ORCID https://orcid.org/0000-0001-9632-2415
Lydia SamuelsDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.ORCID https://orcid.org/0009-0006-2214-6213
Nousheen InayatDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.
Sukruthi ThungaDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.
Elizabeth NobleDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.ORCID https://orcid.org/0000-0003-0958-2601
Dorice L VieraDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.
Deborah AdenikinjuDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.
Charmaine RoyalDepartment of African and African American Studies, Duke University, Durham, North Carolina, United States of America.
Angela Odoms-YoungCollege of Human Ecology, Division of Nutritional Sciences, Cornell Center for Health Equity, Cornell University, Ithaca, New York, United States of America.
Prince Michael AmegborDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.ORCID https://orcid.org/0000-0001-7701-2585
Emmanuel PeprahDepartment of Global and Environmental Health, NYU School of Global Public Health, New York, New York, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSickle cell disease (SCD) stands as one of the most prevalent genetic disorders in the United States (U.S.) that causes severe consequences such as organ damage and excruciating pain. Alarmingly, recent literature indicates a decline in the number of people living with SCD (PLWSCD) seeking professional care - hinting at an avoidance of the healthcare system. Therefore, this scoping review synthesizes the evidence regarding barriers and facilitators influencing healthcare utilization among PLWSCD within the U.S.

methodsTo map the current literature on SCD management and provide a comprehensive overview of the current knowledge gaps regarding healthcare utilization for PLWSCD, a scoping review was conducted. A systematic search of articles reporting on the utilization of healthcare among PLWSCD in the U.S using seven data sources was conducted on March 24, 2023, without any restrictions on publication date and language. To capture any additional articles, the search was updated on March 4, 2024. Two reviewers independently assessed studies for inclusion, data extraction, and risk of bias (RoB). MAIN

resultsA total of 708 articles were screened; 70 met the study criteria. Results indicated that the four most common barriers were social (n = 25) interpersonal (n = 23), economic (n = 15), and institutional level factors (n = 11). The top four most common facilitators were technology (n = 9), education (n = 7), autonomy (n = 6), and a positive patient-provider relationship (n = 6). The most common forms of healthcare utilization were inpatient or hospital admissions (n = 19) and emergency department (ED) visits (n = 18). Evidence-based interventions (EBI) found to decrease healthcare avoidance included individualized pain plans (IPPs) (n = 4) and quality improvement (QI) strategies (n = 3).

conclusionThis scoping review identified complex multilevel barriers that impede healthcare utilization, and facilitators likely to promote healthcare utilization among PLWSCD in the U.S. Future research should prioritize developing and evaluating comprehensive, multi-level interventions that address identified barriers while leveraging facilitators to improve healthcare engagement and outcomes for this vulnerable population. Healthcare systems and health policies must urgently adopt and integrate evidence-based strategies to rebuild trust and ensure equitable, accessible care for PLWSCD.

Indexed as

Anemia, Sickle CellHealth Services AccessibilityPatient Acceptance of Health CareHumansUnited States

Identifiers

PMID42406873
PMCPMC13336462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.